1. Home
  2. RUN vs ADMA Comparison

RUN vs ADMA Comparison

Compare RUN & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrun Inc.

RUN

Sunrun Inc.

HOLD

Current Price

$17.91

Market Cap

4.2B

Sector

Miscellaneous

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$19.86

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUN
ADMA
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
RUN
ADMA
Price
$17.91
$19.86
Analyst Decision
Buy
Strong Buy
Analyst Count
18
2
Target Price
$20.63
$28.50
AVG Volume (30 Days)
7.1M
2.9M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
205.35
EPS
N/A
0.86
Revenue
$2,316,656,000.00
$488,559,000.00
Revenue This Year
$18.66
$22.19
Revenue Next Year
$6.33
$24.33
P/E Ratio
N/A
$23.11
Revenue Growth
13.79
27.63
52 Week Low
$5.38
$13.50
52 Week High
$22.44
$25.67

Technical Indicators

Market Signals
Indicator
RUN
ADMA
Relative Strength Index (RSI) 46.24 66.02
Support Level $17.47 $19.13
Resistance Level $18.91 $20.22
Average True Range (ATR) 1.02 0.73
MACD -0.01 0.05
Stochastic Oscillator 20.10 79.44

Price Performance

Historical Comparison
RUN
ADMA

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: